JFS Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Hold	40	–	–	﹤0.01%	934
2026 Q1	$13.2K	Sell	40 -5	-11%	-$1.7K	﹤0.01%	850
2025 Q4	$17.9K	Buy	45 +10	+29%	+$4.43K	﹤0.01%	781
2025 Q3	$16K	Hold	35	–	–	﹤0.01%	743
2025 Q2	$11.4K	Hold	35	–	–	﹤0.01%	825
2025 Q1	$9.45K	Buy	35 +9	+35%	+$2.31K	﹤0.01%	896
2024 Q4	$6.12K	Buy	26 +2	+8%	+$526	﹤0.01%	1050
2024 Q3	$6.6K	Buy	24 +3	+14%	+$781	﹤0.01%	1015
2024 Q2	$5.1K	Hold	21	–	–	﹤0.01%	1063
2024 Q1	$3.14K	Buy	21 +6	+40%	+$1K	﹤0.01%	1280
2023 Q4	$2.87K	Sell	15 -11	-42%	-$1.87K	﹤0.01%	1274
2023 Q3	$4.61K	Buy	26 +5	+24%	+$954	﹤0.01%	1020
2023 Q2	$3.99K	Buy	21 +8	+62%	+$1.59K	﹤0.01%	1100
2023 Q1	$2.6K	Sell	13 -11	-46%	-$2.31K	﹤0.01%	1268
2022 Q4	$5.7K	Hold	24	–	–	﹤0.01%	940
2022 Q3	$5K	Buy	24 +14	+140%	+$2.67K	﹤0.01%	959
2022 Q2	$1K	Sell	10 -5	-33%	-$709	﹤0.01%	1452
2022 Q1	$2K	Buy	15 +5	+50%	+$762	﹤0.01%	1363
2021 Q4	$2K	Buy	+10	New	+$1.86K	﹤0.01%	1018